__timestamp | Ligand Pharmaceuticals Incorporated | Wave Life Sciences Ltd. |
---|---|---|
Wednesday, January 1, 2014 | 9136000 | 2395000 |
Thursday, January 1, 2015 | 5807000 | 9057000 |
Friday, January 1, 2016 | 5571000 | 393000 |
Sunday, January 1, 2017 | 5366000 | 79309000 |
Monday, January 1, 2018 | 6337000 | 134428000 |
Tuesday, January 1, 2019 | 11347000 | 175431000 |
Wednesday, January 1, 2020 | 30419000 | 124165000 |
Friday, January 1, 2021 | 62176000 | 121875000 |
Saturday, January 1, 2022 | 52827000 | 10114000 |
Sunday, January 1, 2023 | 35049000 | 9206000 |
Data in motion
In the ever-evolving pharmaceutical landscape, cost efficiency is a critical metric for success. This analysis delves into the cost of revenue trends for Ligand Pharmaceuticals Incorporated and Wave Life Sciences Ltd. over the past decade, from 2014 to 2023. Ligand Pharmaceuticals, known for its innovative drug discovery platform, has maintained a relatively stable cost of revenue, peaking in 2021 with a 620% increase from its 2014 figures. In contrast, Wave Life Sciences, a leader in genetic medicine, experienced a dramatic surge, with costs skyrocketing by over 7,200% from 2016 to 2019. However, recent years have seen a decline, with 2023 figures dropping by 95% from their 2019 peak. This comparative analysis highlights the dynamic nature of cost management in the pharmaceutical industry, offering insights into strategic financial planning and operational efficiency.
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Annual Comparison of SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline
5 Year Trend in Average Market Capitalization for AbbVie
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Number of Employees for Top 10 Healthcare Companies
Number of Employees for Top 10 Pharma Companies
Average Market Capitalization of Abbvie Annually
5 Year Trend in Market Capitalization for AbbVie
5 Year Trend in Average Market Capitalization for AbbVie
Comparison of Net Income Margin for Glaxosmithkline, AstraZeneca, Takeda, and Eli Lilly Over the Last 8 Quarters